Evidence map›Paper›PMID 39553954›Full record

ArticlebioRxiv : the preprint server for biology2024

ROBUST DISCOVERY OF MUTATIONAL SIGNATURES USING POWER POSTERIORS.

Catherine Xue, Jeffrey W Miller, Scott L Carter, Jonathan H Huggins

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Catherine XueHarvard University, Department of Biostatistics.ORCID 0000-0002-5518-122X
Jeffrey W MillerHarvard University, Department of Biostatistics.ORCID 0000-0001-7718-1581
Scott L CarterDana Farber Cancer Institute, Department of Data Science.ORCID 0000-0002-8480-1475
Jonathan H HugginsBoston University, Department of Mathematics & Statistics.ORCID 0000-0002-9256-6727

Funding

Interdisciplinary training: Statistical Genetics/Genomics and Computational BiologyT32GM135117 · NIGMS · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Curtis Huttenhower, XIHONG LIN · 2020 to 2026
$3.1M
Statistical methods for cancer genomics and cell-free DNA analysisR01CA240299 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI MILLER, JEFFREY WAYNE · 2020 to 2024
$1.7M
Robust, scalable, and accurate discovery of mutational signaturesR01GM144963 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HUGGINS, JONATHAN · 2021 to 2023
$592k
NCI NIH HHS R01 CA240299NIGMS NIH HHS R01 GM144963NIGMS NIH HHS T32 GM135117
6 · The paper itself

Abstract

Mutational processes, such as the molecular effects of carcinogenic agents or defective DNA repair mechanisms, are known to produce different mutation types with characteristic frequency profiles, referred to as mutational signatures. Non-negative matrix factorization (NMF) has successfully been used to discover many mutational signatures, yielding novel insights into cancer etiology and targeted therapies. However, the NMF model is only a rough approximation to reality, and even small departures from this assumed model can have large negative effects on the accuracy and reliability of the results. We propose a new approach to mutational signatures analysis that improves robustness to misspecification by using a power posterior for a fully Bayesian NMF model, while employing a sparsity-inducing prior to automatically infer the number of active signatures. In extensive simulation studies, we find that our proposed approach recovers more true signatures with greater accuracy than current leading methods. On whole-genome sequencing data for six cancer types from the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, we find that our method is able to accurately recover more signatures than the current state-of-the-art.

Identifiers

PMID39553954
PMCPMC11566004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.